SCHEMBL18735182

SCHEMBL18735182

CCN(CC)C(=O)C(NC(=O)C(C)C)C(C)SC(=O)CC(=O)OC(C)C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18735147 0.90 LMNA (0.31) LMNA
SCHEMBL18735154 0.90 CNR2 (0.31) —
SCHEMBL18734947 0.88 — —
SCHEMBL18734971 0.88 — —
SCHEMBL18735162 0.87 MGAM (0.35) —
SCHEMBL18735146 0.87 LMNA (0.32) LMNA
SCHEMBL18734933 0.82 — —
SCHEMBL18735075 0.82 LMNA (0.33) LMNA
SCHEMBL18734929 0.80 METAP2 (0.30) —
SCHEMBL18735192 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback